Veterans' stomach bug battle: tailored treatment may beat standard care
NCT ID NCT07104318
First seen Jun 27, 2026 · Last updated Aug 05, 2026 · Updated 2 times
Summary
This study compares a personalized treatment plan for H. pylori infection against the usual standard care in 360 veterans. The personalized approach uses genetic testing and antibiotic sensitivity to choose the best drugs. The goal is to see which method cures more infections with fewer side effects.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HELICOBACTER PYLORI are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
VA San Diego Healthcare System, San Diego, CA
San Diego, California, 92161-0002, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Stomach bug clues: can infection patterns forecast early cancer behavior?
- Shorter h. pylori treatment shows promise in new trial
- New stomach acid drug could boost h. pylori cure rates
- New acid blocker may beat standard treatment for stomach bug
- West indies stomach cancer study seeks hidden infection clues
- Argon plasma zaps stomach bugs in new trial